###begin article-title 0
The p80 homology region of TEP1 is sufficient for its association with the telomerase and vault RNAs, and the vault particle
###end article-title 0
###begin p 1
###xml 606 642 606 642 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oupjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oupjournals.org
###end p 1
###begin p 2
###xml 567 578 567 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 957 965 957 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 396 401 <span type="species:ncbi:4932">yeast</span>
###xml 526 531 <span type="species:ncbi:4932">yeast</span>
TEP1 is a protein component of two ribonucleoprotein complexes: vaults and telomerase. The vault-associated small RNA, termed vault RNA (VR), is dependent upon TEP1 for its stable association with vaults, while the association of telomerase RNA with the telomerase complex is independent of TEP1. Both of these small RNAs have been shown to interact with amino acids 1-871 of TEP1 in an indirect yeast three-hybrid assay. To understand the determinants of TEP1-RNA binding, we generated a series of TEP1 deletions and show by yeast three-hybrid assay that the entire Tetrahymena p80 homology region of TEP1 is required for its interaction with both telomerase and VRs. This region is also sufficient to target the protein to the vault particle. Electrophoretic mobility shift assays using the recombinant TEP1 RNA-binding domain (TEP1-RBD) demonstrate that it binds RNA directly, and that telomerase and VRs compete for binding. VR binds weakly to TEP1-RBD in vitro, but mutation of VR sequences predicted to disrupt helices near its central loop enhances binding. Antisense oligonucleotide-directed RNase H digestion of endogenous VR indicates that this region is largely single stranded, suggesting that TEP1 may require access to the VR central loop for efficient binding.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 115 116 115 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 837 838 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 839 840 839 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 1039 1043 <span type="species:ncbi:10090">mice</span>
Vaults are 13 million Dalton ribonucleoprotein particles (RNPs) of unknown function with dimensions of 42 x 75 nm (1-3). Vault morphology is reminiscent of a barrel with a cap on each end and is highly conserved across a wide range of species. The basic vault structure is formed by multimerization of a predicted 96 copies of the 96 kDa major vault protein (MVP), which makes up >70% of the particle mass and forms the entire exterior shell of vaults (4). Virtually all of the MVPs of the cell biochemically fractionate as a large particle, suggesting that all or most MVP monomers are incorporated into vaults. Although the function of vaults has not been determined, roles have been proposed with respect to nucleocytoplasmic trafficking, multi-drug resistance and, more recently, as a scaffold for epidermal growth factor signaling (5-9). Despite their presence in a wide variety of evolutionarily diverse organisms and upregulation in several multi-drug resistant cancer cell lines, mammalian vaults are not required for survival, as mice lacking MVP are viable, do not display increased sensitivity to cytostatic drugs, and have no obvious phenotypic defects (10).
###end p 4
###begin p 5
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 836 837 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 1026 1027 1026 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1028 1030 1028 1030 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1031 1033 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 433 438 <span type="species:ncbi:9606">human</span>
###xml 443 451 <span type="species:ncbi:8400">bullfrog</span>
###xml 636 639 <span type="species:ncbi:10116">rat</span>
Vaults contain two other proteins: vault poly (ADP-ribose) polymerase (VPARP) and telomerase-associated protein 1 (TEP1), as well as a small untranslated vault RNA (VR) (11-13). Each of these components is present in multiple copies in vaults, but their precise stoichiometry with respect to a single vault is unclear, and it is not known whether all vaults contain equal numbers of these components. Moreover, some species, such as human and bullfrog, express multiple-related VRs that can associate with the vault particle (8,11). Cryoelectron microscope (cryoEM) image reconstructions of intact or RNase-treated vaults purified from rat liver have resolved the structure to 31 and 22 A resolutions, respectively. Difference imaging between intact and RNase-treated vaults localizes VR to the interior ends of each of the vault caps (3,14). The precise localization of VPARP and TEP1 within the vault particle is not yet known. Both proteins, as well as VR, are also found in non-vault-associated fractions within the cell (8,12,13).
###end p 5
###begin p 6
###xml 133 144 133 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 212 223 212 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 244 252 244 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 341 349 341 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 388 399 388 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 638 654 638 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 732 740 732 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 1001 1003 1001 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 1004 1006 1004 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1091 1093 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 1111 1119 1111 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1311 1313 1311 1313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 1314 1316 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 1740 1742 1740 1742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 638 654 <span type="species:ncbi:562">Escherichia coli</span>
###xml 975 980 <span type="species:ncbi:4932">yeast</span>
###xml 1185 1189 <span type="species:ncbi:10090">mice</span>
###xml 1305 1309 <span type="species:ncbi:10090">mice</span>
###xml 1393 1397 <span type="species:ncbi:10090">mice</span>
###xml 1438 1443 <span type="species:ncbi:10090">mouse</span>
###xml 1492 1496 <span type="species:ncbi:10090">mice</span>
###xml 1544 1548 <span type="species:ncbi:10090">mice</span>
###xml 1599 1603 <span type="species:ncbi:10090">mice</span>
TEP1 is an RNA-binding protein that interacts with mammalian telomerase in cell extracts and was cloned based upon its homology with Tetrahymena p80, which also co-purified with telomerase activity and binds the Tetrahymena telomerase RNA (TR) in vitro (15-17). A schematic illustration of the various domains identified in TEP1 is shown in Figure 1. Disruption of the p80/p95 complex in Tetrahymena leads to telomere lengthening (18). However, p80 is not a core telomerase component and is not required for telomerase activity (18-20). Furthermore, recombinant p80 binds poorly or not at all to other co-expressed telomerase subunits in Escherichia coli or insect cell extracts and non-specifically interacts with a number of RNAs in vitro, in addition to its interaction with TR (19). The precise function of mammalian TEP1 is also not known, but it has been shown to be one of four components of purified vaults and to interact with the VR and mammalian TR in an indirect yeast three-hybrid assay (13,16). Immunoprecipitation of endogenous TEP1 co-immunoprecipitates telomerase activity (16,17). Despite the in vitro association between TEP1 and telomerase activity, Tep1-deficient mice have no known telomerase-related defect, as telomerase activity, TR levels and telomere length are normal in these mice (21,22). However, VR levels are reduced in all tissues studied from Tep1-deficient mice and VR stability is markedly reduced in mouse embryonic fibroblasts (MEFs) derived from these mice in comparison with MEFs derived from wild-type mice. Furthermore, vaults purified from Tep1-deficient mice do not contain VR, demonstrating genetically and biochemically that TEP1 is required for the association of VR with the vault particle (22).
###end p 6
###begin p 7
###xml 183 191 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 533 535 533 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 536 538 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
VPARP is a member of the PARP family of proteins and is the only vault-associated protein demonstrated to have enzymatic activity, as it is able to ADP-ribosylate both itself and MVP in vitro, although the functional significance of this modification is not known (12). In addition to its localization in the vault particle, VPARP is seen at the mitotic spindle using immunofluorescence, and immunoprecipitation of VPARP from lysates derived from VPARP transfected cells results in the co-immunoprecipitation of telomerase activity (12,23). Like TEP1, Vparp-deficient mice also have no known phenotypic defects, telomerase-related or otherwise (22,23). Vaults purified from livers of either Vparp- or Tep1-deficient mice also appear morphologically normal (22,23).
###end p 7
###begin p 8
###xml 154 162 154 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 231 238 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 635 637 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 322 325 <span type="species:ncbi:10116">rat</span>
###xml 515 521 <span type="species:ncbi:9606">humans</span>
###xml 526 535 <span type="species:ncbi:8400">bullfrogs</span>
###xml 584 590 <span type="species:ncbi:9606">humans</span>
###xml 595 600 <span type="species:ncbi:10090">mouse</span>
VR is an RNA polymerase III transcript that does not appear to be further processed, and thus retains its 3' polyuridylate tail, binds the La autoantigen in vitro and is found stably complexed with La apart from the vault particle in vivo (24). Interestingly, La has also been found to co-purify with vaults purified from rat livers. The genes for VR have been identified and sequenced for a variety of species, and the RNAs are all predicted to fold into a highly conserved structure (8,25). Some species, such as humans and bullfrogs, express multiple-related VRs, and two species, humans and mouse, each contains a VR pseudogene (8,25,26). The function of VR is not known, but as it is unimportant for the structural integrity of the vault particle, it is proposed to play a functional rather than structural role in the complex (14,27).
###end p 8
###begin p 9
###xml 276 287 276 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 649 657 649 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 214 219 <span type="species:ncbi:4932">yeast</span>
The goal of the current study is to determine whether TEP1, a component of both vault and telomerase RNPs, each containing an unrelated RNA, VR or TR, binds singly or simultaneously to these RNA species. Using the yeast three-hybrid system, we determined that the entire TEP1 Tetrahymena p80 homology region is required for its interaction with VR and TR. Electrophoretic mobility shift assays (EMSAs) using a partially purified truncation of TEP1 containing this RNA-binding domain (TEP1-RBD) demonstrate that TEP1 can indeed bind RNA directly, and that, like p80, TEP1 also binds some RNAs non-specifically. However, although TR binds to TEP1-RBD in vitro, only point mutants of mVR that are predicted to disrupt base-pairing near the VR central loop were able to interact with TEP1-RBD, suggesting that other factors are normally required for this association. Furthermore, competition experiments indicate that there is likely only one RNA-binding site, since VR and TR do not simultaneously bind to TEP1-RBD. RNase H digests of extracts containing VR annealed to complementary DNA oligonucleotides (ODNs) were synthesized in order to identify single-stranded regions of VR. These experiments suggest that the central loop of partially purified endogenous VR forms a more open and single-stranded structure than predicted by thermodynamic models. Combined with the results of our VR mutations, these results suggest that the central loop of VR is important for its interaction with TEP1. Finally, by purifying recombinant vaults generated by co-infecting Sf9 insect cells with baculoviruses expressing MVP and a series of TEP1 truncations, we show that the p80 homology region of TEP1 also contains the vault-interaction domain.
###end p 9
###begin title 10
MATERIALS AND METHODS
###end title 10
###begin title 11
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast three-hybrid analysis
###end title 11
###begin p 12
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1110 1112 1110 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 1113 1115 1113 1115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 68 73 <span type="species:ncbi:4932">yeast</span>
###xml 676 681 <span type="species:ncbi:10090">Mouse</span>
###xml 889 895 <span type="species:ncbi:10090">Murine</span>
###xml 921 926 <span type="species:ncbi:4932">yeast</span>
###xml 1024 1029 <span type="species:ncbi:4932">yeast</span>
Mouse TEP1 deletions were generated by PCR, cloned into the pACT II yeast expression vector and confirmed by sequence analysis. PCR primers were engineered to contain an NcoI site for cloning purposes and are as follows. Forward primers for the following TEP1 amino acid sequences 1-871, 1-740 and 1-580: 5'-AATCCATGGCTATGGAGAAGCTCTGTGGGCATG-3'; 201-871: 5'-AATCCATGGCTCAAGAAGAAGAAAGCACAGAAG-3'; 270-871: 5'-AATCCATGGCTTCTGACCTTACCCGGGCATC-3'; and 400-871: 5'AATCCATGGCTCGCCCTCAAAAGACAGAACG-3'. Reverse primers: 1-871, 201-871, 270-871 and 400-871: 5'-AATCCATGGTATGG TATCTAGTTGTCCC-3'; 1-740: 5'-AAT CCATGCGGTGTCTTCACAAATCCTCC-3'; and 1-580: 5'-AATCCATGATCGATAGAGTCATGAGC-3'. Mouse VR was cloned by PCR into the SmaI site of pIII/MS2-1 in sense and antisense orientations using the following primers: forward, 5'-CTGACCCGGGCCAGCTTTAGCTCAGC-3'; reverse, 5'-TTGACCCGGGAAAGGGCCAGGGAGCGCC-3'. Murine TR clones for use in the yeast three-hybrid system have been published previously (16). Plasmids were transformed into the L40i yeast strain and tested for TEP1-VR and TEP1-TR interactions as described previously (13,16,28).
###end p 12
###begin title 13
TEP1-RBD expression and partial purification
###end title 13
###begin p 14
###xml 432 438 432 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 507 508 504 505 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 578 579 569 570 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 581 582 572 573 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1020 1021 1004 1005 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 44 50 <span type="species:ncbi:10090">murine</span>
###xml 432 438 <span type="species:ncbi:562">E.coli</span>
The DNA sequence for amino acids 201-871 of murine TEP1 was PCR amplified and cloned into pET28a using forward and reverse primers containing engineered SalI and NotI sites, respectively, thus fusing the His-T7 tag onto the N-terminus of TEP1-RBD. Forward primer, 5'-ATCTGTCGACAAGAAGAAGAAAGCACAGA AG-3'; reverse primer, 5'-ATAAGAATGCGGCCGCTTATAGTTTATCTAGTTGTCCC-3'. The plasmid was sequenced and transformed into BL21 CodonPlus DE3 E.coli (Stratagene). A 500 ml culture was induced with 1 mM Isopropyl-beta-d-thiogalactopyranoside for 2.5 h at 21degreesC, and lysed in 50 mM NaH2PO4, pH 8, 300 mM NaCl, 0.5% v/v Triton X-100, 10 mug/ml leupeptin by a 1 h incubation with 1 mg/ml lysozyme at 4degreesC followed by sonication (two 10 s pulses at setting 3.5). Cleared lysates were applied to a Ni-NTA column (Novagen) and washed according to the manufacturer's protocol with the final wash and elution containing 100 and 250 mM imidazole, respectively. The eluate was dialyzed into 20 mM Tris, pH 8, 150 mM NaCl, 1 mM MgCl2, 10% glycerol and 1 mM DTT, and stored at -80degreesC.
###end p 14
###begin title 15
Mutagenesis, EMSA and immunoprecipitation
###end title 15
###begin p 16
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 638 640 638 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
VR and TR were PCR amplified using a forward primer engineered to incorporate a T7 promoter sequence to drive transcription and cloned into pUC 118. Point mutants were generated using the Quickchange Mutagenesis Kit (Stratagene), or by a second round of PCR using a transcription template (see below) using a forward or reverse primer incorporating the appropriate nucleotide alteration. Transcription reactions were performed using sequenced VR or TR PCR product templates derived from pUC 118 clones to ensure correct termination of transcription. EMSA was performed as described previously (24) with the following exception: 5 fmol of 32P-CTP radiolabeled RNA was used in each binding reaction and native gels were electrophoresed at 300 V in 0.5x TBE for 1 and 4 h for VR and TR probes, respectively. Competitions were carried out by pre-incubating unlabeled RNA with TEP1-RBD for 10 min prior to the addition of radiolabeled RNA. Dried gels were exposed to PhosphorImager screens and imaged using the Typhoon 9410 (Molecular Dynamics). Immunoprecipitation of mTR/TEP1-RBD complexes was carried out by transferring the binding reaction into 90 mul 1x binding buffer containing 0.1 mg/ml BSA, followed by incubation with 1 mug antibody on ice for 40 min. Fifteen mul Protein A beads were then used to capture the complex by tumbling the tubes for 20 min at 4degreesC. The beads were washed three times with ice-cold binding buffer and boiled in SDS sample buffer.
###end p 16
###begin title 17
RNase H digests
###end title 17
###begin p 18
###xml 632 633 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 116 119 <span type="species:ncbi:10116">rat</span>
###xml 200 203 <span type="species:ncbi:10116">rat</span>
###xml 210 215 <span type="species:ncbi:9606">human</span>
RNase H assays were performed on either P100 extract (RNP) or deproteinized P100 extract (RNA) prepared from either rat fibroblasts or HeLa cells. Antisense ODNs that span almost the entire length of rat VR or human VR1 were synthesized on an Applied Biosystems DNA synthesizer. Ten micrograms of total protein (P100) or deproteinized P100 (RNA), 0.5 mug of antisense ODNs and 0.4 U of RNase H (in a final volume of 25 mul) were incubated at 30degreesC for 1 h. Reactions were phenol:chloroform extracted, and ethanol precipitated in the presence of 10 mug of carrier tRNA and analyzed by northern blotting as described previously (8).
###end p 18
###begin title 19
Baculoviruses, SF9 insect cell infections and vault purifications
###end title 19
###begin p 20
###xml 101 102 101 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 1454 1455 1454 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 1576 1577 1576 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 4 7 <span type="species:ncbi:10116">rat</span>
###xml 37 42 <span type="species:ncbi:9606">human</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
###xml 1014 1019 <span type="species:ncbi:9606">human</span>
The rat MVP-encoding baculovirus and human TEP1-encoding baculovirus have been described previously (4,29). DNA encoding human TEP1 amino acids 1-1650 and 1-125 were generated by PCR, cloned into pFastBac 1 and verified by sequencing. The primers used were as follows. The 1-1650 and 1-125 constructs were both made using the forward primer: 5'-CTACGTCGACCACCATGGAAAAACTCCATGGGCATG-3'. The reverse primer sequence for the 1-1650 clone encodes a C-terminal T7 epitope tag and is 5'-GCTTTCTAGACTAACCCATTTGCTGTCCACCAGTCATGCTAGCCATGAGGTGCCATCTCCGGGAGAG. The reverse primer sequence for the 1-125 clone also encodes a C-terminal T7 epitope tag and is 5'-GCTTTCTAGACTAACCCATTTGCTGTCCACCAGTCATGCTAGCCATGCTGGCAGACACAGTGCTCTTTAG-3'. SalI and XbaI sites engineered into the primers were used to clone the PCR product into pFastBac (Invitrogen). A fragment of the hTEP1 cDNA, spanning the first 911 amino acids, was subcloned into pFastBac1 and engineered with an N-terminal tandem c-myc epitope tag (residues 408-439 of the human c-myc protein) and a C-terminal 6 histidine tag. The final insert sequence was confirmed using fluorescent dideoxy-nucleotide sequencing and automated detection (ABI/PerkinElmer). The resulting 956 amino acid fusion protein has a predicted weight of 108.4 kDa. Viruses were generated according to the protocol of the Bac-to-Bac system (Invitrogen). Sf9 cells were maintained and infected with baculovirus(es) as described previously (4). Recombinant vaults were purified from infected Sf9 cell lysates and analyzed by western blot as described previously (4).
###end p 20
###begin title 21
RESULTS
###end title 21
###begin title 22
###xml 46 52 <span type="species:ncbi:10090">murine</span>
The entire Tetrahymena p80 homology region of murine TEP1 is required for the interaction with vault and telomerase RNAs
###end title 22
###begin p 23
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1111 1120 1111 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 1349 1353 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">His3</italic>
###xml 1670 1679 1670 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 1701 1710 1701 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 1855 1864 1855 1864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1A</xref>
###xml 1885 1894 1885 1894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1B</xref>
###xml 56 62 <span type="species:ncbi:10090">murine</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 151 156 <span type="species:ncbi:4932">yeast</span>
###xml 415 420 <span type="species:ncbi:4932">yeast</span>
###xml 1175 1180 <span type="species:ncbi:4932">yeast</span>
###xml 1393 1398 <span type="species:ncbi:4932">yeast</span>
###xml 1931 1936 <span type="species:ncbi:4932">yeast</span>
###xml 2130 2135 <span type="species:ncbi:4932">yeast</span>
###xml 2263 2268 <span type="species:ncbi:4932">yeast</span>
A truncation consisting of the first 871 amino acids of murine TEP1 has been previously shown to interact with mouse TR and multiple human VRs using a yeast three-hybrid assay (13,16). Briefly, this assay fuses an RNA of interest to the MS2 phage hairpin RNA, which binds to the MS2 coat protein, and can be used to test RNA-protein interactions by driving transcription of a reporter gene in a manner analogous to yeast two-hybrid assays (28). In addition to the p80 region, this 871 amino acid sequence contains four N-terminal 30 amino acid repeats of unknown significance. Since the region of homology between TEP1 and p80 is poorly conserved with other RNA-binding proteins at key residues (30), we decided to test a series of TEP1 truncations for two reasons: first, to determine whether it was possible to separate the RNA-binding activities for VR and TR, which might suggest a functional connection between the two RNAs; and second, if this was not possible, to further define the region of TEP1 critical for binding RNA. TEP1 deletions were made using the 1-871 amino acid region as a starting point (Figure 1A), and these constructs were transformed into the L40i yeast strain, along with plasmids expressing mTR and mVR sense and control, antisense RNAs fused to the MS2 hairpin RNA. An interaction between protein and RNA activates the His3 reporter gene and allows the growth of yeast on media lacking histidine and containing 3-aminotriazole. Both the 1-871 amino acid construct and a construct lacking the 4 N-terminal repeats of TEP1 (amino acids 201-871) were able to bind to both TR and VR in sense but not antisense orientations based on this assay (Figure 1A, constructs 1 and 2; Figure 1B, 1s, 1as, 2s and 2as). Deletion of any sequences in the TEP1-p80 homology region resulted in the loss of RNA-binding ability of both TR and VR (Figure 1A, constructs 3-6 and Figure 1B, 3-6). Western blots of transformed yeast cultures verified that all of the TEP1 deletions were expressed (data not shown), although a substantial portion of construct 3 (amino acids 270-871) is found as a smaller breakdown product in yeast lysates. Thus, the entire p80 homology region (amino acids 201-871) is required for TEP1 to bind both VR and TR in an indirect yeast three-hybrid system; henceforth this domain will be referred to as TEP1-RBD.
###end p 23
###begin title 24
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Partially purified TEP1-RBD binds TR in vitro
###end title 24
###begin p 25
###xml 44 52 44 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 189 195 189 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 532 541 532 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 591 599 591 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1059 1068 1059 1068 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1169 1178 1169 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1299 1308 1299 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1419 1428 1419 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1974 1983 1974 1983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 2113 2120 2113 2120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2176 2178 2176 2178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 2246 2248 2246 2248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 2249 2251 2249 2251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 2252 2254 2252 2254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 2369 2371 2369 2371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 2383 2391 2383 2391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2591 2600 2591 2600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 2651 2662 2651 2662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 2737 2745 2737 2745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 2747 2749 2747 2749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 3029 3038 3029 3038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 3076 3085 3076 3085 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 189 195 <span type="species:ncbi:562">E.coli</span>
###xml 200 206 <span type="species:ncbi:10090">murine</span>
###xml 767 772 <span type="species:ncbi:4932">yeast</span>
Evidence exists that VR and TR bind to TEP1 in vitro and in vivo, but it has not yet been shown that TEP1 binds to these RNAs directly (13,16,22). Therefore, we expressed and purified from E.coli the murine TEP1-RBD fused to the HisT7 N-terminal epitope tag derived from pET28 (see Materials and Methods). We were unable to completely purify the recombinant protein away from contaminating bacterial proteins without washing TEP1-RBD off the Ni-NTA resin. Nevertheless, we were able to partially purify enough recombinant TEP1-RBD (Figure 2A) to determine whether it could interact with RNA in vitro using EMSA. Although full-length mTR binds to TEP1-RBD using EMSA (data not shown), we also transcribed mTR nt 1-223, which is sufficient to interact with TEP1 in the yeast three-hybrid assay (A. Reda and L. Harrington, unpublished data), rather than full-length mTR, to facilitate resolution of the RNA and RNP complexes on native gels. Incubation with increasing amounts of TEP1-RBD induced a small shift in the mobility of the 223 nt mTR probe using EMSA (Figure 2B, lanes 1-4), and this association was competed with pre-incubation of 50x unlabeled full-length TR (Figure 2B, lane 5). Surprisingly, even 250x excess unlabeled mVR was unable to compete with the TR probe for binding to TEP1-RBD (Figure 2B, lane 6), but an mVR variant (see below) did compete with TR probe, although less effectively than TR itself (Figure 2B, compare lanes 7-8 with lane 5). Using more than 80 ng TEP1-RBD in the binding reactions did not result in increased TR binding, nor did using more than 50-fold molar excess of unlabeled TR result in much additional competition with labeled probe (data not shown), indicating that the majority of the RNA is unable to bind despite a high molar excess of protein to target RNA. To test the specificity of RNA binding by TEP1, four non-specific competitor RNAs were used; three RNAs were unable to compete for binding to TEP1 even at 500x excess (Figure 2B, lanes 9-11). The NL15 RNA is an artificial RNA with both single- and double-stranded regions that interacts with the La protein in vivo, but does not bind in a 3' uridylate dependent manner (31). La has previously been shown to interact with the VR and the TR (24,32,33). As La also interacts with the vault particle, this seemed to be a relevant RNA to test for binding to TEP1-RBD (24). However, in vitro transcription of the multiple-cloning site of linearized pBluescript SK+ containing the T7 promoter yielded an RNA, which was able to efficiently compete with TR for binding at 50-fold molar excess (Figure 2B, lane 12). This indicates that TEP1-RBD, like its Tetrahymena p80 homolog, has limited specificity with respect to its affinity for RNA in vitro (19). The specificity of the RNA-protein complex was then further analyzed since the TEP1-RBD protein was only partially purified. We used a monoclonal antibody directed against the T7 epitope tag of the recombinant TEP1-RBD protein to co-immunoprecipitate the mTR (nt 1-223) probe (Figure 2C, lanes 1 and 2). Control antibodies (Figure 2C, lanes 3-6) did not bring down either the TEP1-RBD protein or the mTR RNA, demonstrating that the band shift seen using EMSA was specifically due to binding to TEP1-RBD.
###end p 25
###begin title 26
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
A VR variant has an enhanced ability to bind TEP1-RBD in vitro
###end title 26
###begin p 27
###xml 70 78 70 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 312 321 312 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 459 468 459 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 550 554 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mvg1</italic>
###xml 559 563 559 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mvg2</italic>
###xml 579 583 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mvg1</italic>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 1006 1014 1002 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1139 1148 1135 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 374 379 <span type="species:ncbi:9606">human</span>
###xml 431 437 <span type="species:ncbi:10090">murine</span>
###xml 514 519 <span type="species:ncbi:10090">mouse</span>
###xml 642 648 <span type="species:ncbi:10090">murine</span>
Since unlabeled mVR could not compete with TR for binding to TEP1-RBD in vitro, we repeated the EMSAs using radiolabeled VR transcripts. When labeled mVR was incubated with TEP1-RBD, no RNP complex was observed, as might be expected from the inability of mVR to compete with labeled mTR for binding to TEP1-RBD (Figure 3A, left panel). In contrast, when we used the related human hVR1, we detected a low-level interaction with the murine TEP1-RBD using EMSA (Figure 3A, right panel). We recently reported that the mouse genome contains two VR genes, mvg1 and mvg2; however, only mvg1 is expressed (25). The second, a pseudogene, was the only murine VR clone identified from our original genomic screen for VR sequences and was initially presumed to be the one and only VR gene. This VR pseudogene (henceforth termed PsimVR) contains only 8 nt changes as compared with mVR, and is predicted to form into the evolutionarily conserved VR structure. Thus, we had initially expressed the PsimVR 'coding region' in vitro using a T7 promoter and determined that this VR pseudotranscript is also able to interact with TEP1-RBD in mobility shifts (Figure 3B, lane 4).
###end p 27
###begin p 28
###xml 130 138 130 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 212 219 210 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 297 304 295 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 894 903 886 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 1062 1071 1054 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
###xml 1151 1153 1143 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 1775 1784 1765 1774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
This observation provided a starting point for a mutational analysis strategy to determine why mVR was unable to bind to TEP1-RBD in vitro. PsimVR sequences were replaced with mVR sequences in a stepwise manner (Table 1) and assayed for the loss of binding to TEP1 using EMSA. The first column of Table 1 indicates the position of the 8 nt differences between PsimVR and mVR, and subsequent columns indicate intermediate mVR sequences after nucleotides were altered to revert to the mVR sequence 1 or 2 nt at a time. We were able to revert the PsimVR sequence back to the mVR sequence without losing binding to TEP1-RBD until reversion was attempted at either nt 70 or 73. Once the key residues responsible for PsimVR's interaction with TEP1-RBD were identified, these residues were altered in mVR, and it was confirmed using EMSA that this mVR double mutant is able to interact with TEP1-RBD (Figure 3B, compare lanes 4, 6 and 12). The double mutant alters the base pairing from Watson-Crick to wobble, and is predicted to open a loop in this region of the VR (Figure 3C, left and center structures) using the mfold RNA structure prediction program (34). Because this structure borders the conserved central loop of VR (defined as the region where all three arms of the VR converge in the nine different VR sequences identified across the various species to date), we hypothesized that mutations opening up the central loop might also increase TEP1 binding. Novel mutations in unmodified mVR, which might weaken the stability of the helix adjacent to the central loop without grossly altering the predicted structure of VR, were synthesized. One mutation, C78-->A, showed enhanced binding to TEP1-RBD similar to the mVR double mutant (data not shown) (results summarized in Figure 3C, right structure).
###end p 28
###begin p 29
###xml 310 318 310 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 452 460 452 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
###xml 568 577 568 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 1119 1127 1119 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4</xref>
The specificity of the interaction between the mVR double mutant and TEP1-RBD was tested using a number of unlabeled competitor RNAs. Addition of increasing amounts of TEP1-RBD to the mobility shift binding reactions resulted in an increasingly intense band representing the mVR double mutant-protein complex (Figure 4, lanes 1-4). Pre-incubation with 50x excess of the unlabeled VR double mutant competed most of mobility shift, as did 50x excess TR (Figure 4, lanes 5 and 6). However, not all of the labeled RNA could be competed, similar to TR competition results (Figure 2B). This VR/TR competition for binding to TEP1-RBD indicates that it is likely that either VR or TR, but not both simultaneously, is able to bind to TEP1. Increasing the amount of TEP1-RBD to more than 80 ng did not result in increased VR binding, nor did incubation with more than 50x unlabeled VR double mutant result in additional competition with labeled probe (data not shown). The same four non-specific competitor RNAs were used as with labeled TR, with identical results; again only the SK+ transcript was able to compete for binding (Figure 4, lanes 7-10). Addition of the anti-T7 monoclonal antibody to the binding reaction also resulted in a faint supershift on EMSA (data not shown).
###end p 29
###begin title 30
RNase H mapping of VR indicates that regions surrounding the central loop are single stranded
###end title 30
###begin p 31
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 368 376 368 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 445 453 445 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 557 558 557 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 1040 1049 1040 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 1181 1190 1181 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 1565 1574 1565 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 2036 2045 2036 2045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 2060 2062 2060 2062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 2297 2306 2297 2306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 2523 2530 2523 2530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2619 2628 2619 2628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 2928 2934 2928 2934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 360 363 <span type="species:ncbi:10116">rat</span>
###xml 419 425 <span type="species:ncbi:10090">murine</span>
###xml 434 439 <span type="species:ncbi:9606">human</span>
###xml 753 756 <span type="species:ncbi:10116">rat</span>
###xml 793 796 <span type="species:ncbi:10116">rat</span>
###xml 801 806 <span type="species:ncbi:9606">human</span>
###xml 998 1001 <span type="species:ncbi:10116">rat</span>
###xml 1173 1176 <span type="species:ncbi:10116">rat</span>
###xml 1953 1956 <span type="species:ncbi:10116">rat</span>
###xml 2136 2141 <span type="species:ncbi:9606">human</span>
###xml 2465 2468 <span type="species:ncbi:10116">rat</span>
###xml 2473 2478 <span type="species:ncbi:9606">human</span>
###xml 2742 2745 <span type="species:ncbi:10116">rat</span>
###xml 2750 2755 <span type="species:ncbi:9606">human</span>
We hypothesized that in vivo the central loop of the VR may be in a more open conformation that may facilitate TEP1 binding. To determine whether sequences in the central loop of the VR were available for base pairing, we used an oligodeoxynucleotide-directed RNase H cleavage assay (35). We undertook a preliminary analysis of the secondary structure of both rat VR (Figure 5, left panels), which is highly related to murine VR, and human VR1 (Figure 5, right panels) using this assay. Vault-associated VR was obtained from resuspended high speed (100 000 g) pellets and deproteinated VR obtained from phenol:chloroform extraction of these resuspended pellets. A series of overlapping ODNs complementary to the VRs were each annealed to VR from either rat fibroblast or HeLa cell lysates for rat and human VRs, respectively. RNase H was then added to cleave RNA-DNA hybrids, which form in regions where RNA secondary structure is largely single stranded (35). The extent of cleavage of the 141 nt rat VR was analyzed by northern blotting (Figure 5A). In the absence of VR-associated vault proteins, three ODNs, 21-40, 54-70 and 68-85, directed nearly complete cleavage of rat VR (Figure 5A, lower left panel, RNA). In addition, antisense ODNs 11-27, 38-53 and 102-125 also led to varying amounts of digestion of the VR, whereas the remaining four ODNs (80-95, 103-118, 110-129 and 126-143) had either no effect or directed <5% cleavage of the VR. When vault proteins remain associated with VR, a similar pattern of cleavage is seen by ODNs 21-40, 54-70 and 68-85 (Figure 5A, upper left panel, RNP), whereas the remaining seven ODNs were presumably unable to hybridize with VR, as only minimal cleavage of the VR was observed. These results suggest that bases 21-40 and 54-85 are in an open conformation available for base pairing in the VR whether or not protein is associated. These data are inconsistent with the predicted secondary structure of the rat VR, which indicates that bases 25-85 are base paired in a stem-loop structure (Figure 5B, left panel) (11). Similar results were obtained using ODN-directed cleavage of the 98 nt human VR (hVR1). In the absence of VR-associated vault proteins, ODNs 21-38 and 50-65 directed complete cleavage of hVR1, and ODN 39-53 led to partial cleavage (Figure 5A, lower right panel, RNA). In the presence of vault proteins, these three ODNs again led to the most substantial cleavage of VR. According to these data, both rat and human VR have a significantly more open structure in vivo in the regions surrounding the central loop than was predicted by thermodynamic models (Figure 5B, left and right panels). We found minor differences between protein-bound and deproteinated RNA, but overall the rat and human VRs were found to be single stranded in regions of VR that are poorly conserved in sequence across species. That may indicate that it is the structure and not the sequence per se that is important for TEP1-RBD binding.
###end p 31
###begin title 32
The p80 region of TEP1 also binds vaults
###end title 32
###begin p 33
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 267 269 267 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 497 506 497 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 754 755 754 755 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 1032 1041 1032 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 1197 1206 1197 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 1266 1275 1266 1275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 1375 1384 1375 1384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 1466 1475 1466 1475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 1497 1506 1497 1506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 1669 1678 1669 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 1696 1705 1696 1705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 2205 2208 2205 2208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sf9</italic>
###xml 2427 2438 2427 2438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 2529 2540 2529 2540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tetrahymena</italic>
###xml 61 66 <span type="species:ncbi:4932">yeast</span>
###xml 1850 1856 <span type="species:ncbi:10090">murine</span>
Although TEP1 did not interact with either MVP or VPARP in a yeast two-hybrid assay (36), TEP1 does interact directly with MVP, as co-infection of baculoviruses expressing TEP1 and MVP generates vault-like particles in insect cells that, when purified, contain TEP1 (29). Thus, TEP1 may be able to interact with intact vault particles but not MVP monomers. In order to identify a TEP1-MVP interaction domain, we generated a series of TEP1 truncations for use in the baculovirus expression system (Figure 6A). Baculoviruses expressing the various TEP1 truncations were then used to infect Sf9 insect cell cultures, either alone or in combination with an MVP-expressing baculovirus. Vaults were purified from the co-infected cells as described previously (4). As a final purification step, fractions enriched in recombinant vaults are layered over a 10-60% discontinuous sucrose gradient; vaults comprising HisT7-epitope tagged MVP subunits were used in this study. These particles fractionate predominantly in the 45% sucrose layer (Figure 6B, 'MVP' panel). When TEP1 truncations were expressed without MVP, the vault purification scheme removed each truncation prior to the sucrose gradient step [Figure 6B, 1-3, upper (-) panels]. When expressed together with MVP [Figure 6B, 1-3, lower (+) panels], some TEP1 truncations were seen to co-purify with the recombinant vaults [Figure 6B, 1-3, lower (+) panels]. Truncations consisting of amino acids 1-1650 and 1-911 (Figure 6A, constructs 1 and 2; Figure 6B, panels 1 and 2) each co-purified with vaults, whereas a truncation consisting of amino acids 1-125, which contains the 4 N-terminal repeats, failed to interact (Figure 6A, construct 3 and Figure 6B, panel 3). By deduction, amino acids 126-911 contain a vault-interaction domain. A fourth TEP1 construct, consisting of amino acids 201-1650 of murine TEP1, also interacted with vaults even though it was poorly expressed in insect cells, possibly due to the deletion of the TEP1 N-terminus (data not shown). Therefore, the p80 region of TEP1 (amino acids 201-911) appears to contain both the RNA-binding and vault-interaction domains. The VR is not present in the baculovirus expression system, and Sf9 insect cells do not contain endogenous vault components, so the TEP1-vault interaction is not mediated by VR. The mapping of a vault-interaction domain to this conserved region suggests the intriguing possibility that Tetrahymena might contain vaults or a protein conferring a related function. A database search of the Tetrahymena genome did not identify an MVP homolog, although assembly of the sequences for this genome is not yet complete (The Institute for Genomic Research website at ).
###end p 33
###begin title 34
DISCUSSION
###end title 34
###begin p 35
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b37">37</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b38">38</xref>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b39">39</xref>
###xml 1256 1258 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 1316 1318 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 1953 1955 1953 1955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b40">40</xref>
###xml 2252 2254 2252 2254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 409 415 <span type="species:ncbi:10090">murine</span>
###xml 1498 1503 <span type="species:ncbi:4932">yeast</span>
PSI-blast searches using the amino acid sequence of p80 have previously identified two conserved regions that together span the entire length of the protein. First, the TROVE (Telomerase, Ro and Vault) module was identified as an evolutionarily conserved (presumed) multi-domain region found in TEP1, p80, Ro60 and a number of uncharacterized bacterial proteins (30). This region spans amino acids 227-685 of murine TEP1. Ro60 binds to small RNAs termed 'Y RNAs' along with the La autoantigen in a small RNP complex and has been proposed to contain an RNA recognition motif (RRM domain) based upon the presence of RNP-1 and RNP-2 motifs that are the hallmark of this domain (37,38). However, putative RRMs in p80 and TEP1 have an unusually short spacing of the RNP-1 and RNP-2 motifs and contain conserved polar residues in regions that are non-polar in other RRMs (30). The second domain found using databases searches of p80 is a von Willebrand type A (vWA) domain, which can be involved in a number of functions such as binding to metals, or mediating protein-protein interactions, often in extracellular proteins or in multiprotein complexes (39). This domain is also found adjacent to the TROVE module in TEP1, and corresponds to amino acids 678-861 (29). Interestingly, a vWA domain is found in VPARP as well (30). Our study indicates that an intact TROVE module is required for RNA-binding activity, but we were unable to remove the vWA sequences from the p80 homology region of TEP1 in our yeast three-hybrid assay without interfering with the ability of TEP1 to bind RNA. Since vWA domains are not known to bind RNA, it is possible that the removal of this region disrupts the conformation of the RNA-binding domain in the TROVE module. An analysis of Ro60 similarly determined that even small amino acid deletions in the protein led to the loss of binding to Y RNAs, so it appears that this aspect of the two proteins has also been conserved (40). As we have also mapped the vault-interaction domain of TEP1 to the p80 homology region, either the TROVE module or the vWA domain must mediate this interaction. TEP1 interacts directly with MVP in the insect cell expression system, and is not dependent upon VR for its association with vaults (29). Thus, it is not clear what mechanism targets VR but not TR into the vault particle. One possibility is that since the RNA-binding and vault-binding regions of TEP1 are either in close proximity or overlap, binding of TR to TEP1 could interfere with the ability of the protein to complex with vaults, while binding of VR to TEP1 could promote the TEP1-vault interaction. However, the effect of VR or TR on the stability of the TEP1-vault association is difficult to assess using the insect cell expression system, since the vault purification scheme incorporates an RNase treatment step to remove ribosomes.
###end p 35
###begin p 36
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 695 702 695 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1255 1263 1255 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1398 1406 1398 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5</xref>
###xml 1563 1571 1563 1571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1664 1672 1664 1672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1831 1838 1831 1838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 2568 2576 2568 2576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 458 461 <span type="species:ncbi:10116">rat</span>
Since both VPARP and TEP1 associate with vaults and telomerase (16,17,23), it is possible that there is a functional connection between the two RNPs. The present study indicates that VR or TR, but not both, can interact with a given TEP1 molecule, so it does not seem that VR could directly associate with the telomerase complex via TEP1 without displacing TR. Likewise, neither telomerase activity nor telomerase RNA has been found associated with purified rat liver vaults or vaults immunoprecipitated from tissue culture cells, respectively, so it does not appear likely that either RNA is to be found in the other RNP complex (13,26). The results of our RNase H experiments suggest that the in vivo structure of the VR diverges significantly from structure predictions based upon thermodynamic models. Specifically, the left and right arms of VR, which are essentially the only regions of the RNA that are not conserved across species or even within a single species when multiple VRs are present, are largely single stranded. The central loop of purified endogenous VR is, therefore, considerably larger than seems thermodynamically likely, which may be due to binding of TEP1 to the conserved lower region of the loop. It also seems likely that the in vitro transcribed VR used in EMSA might fold into a structure resembling the more thermodynamically favorable predicted structures shown in Figure 5, rather than a structure containing large stretches of single-stranded RNA. This would explain why only a small fraction of the RNA interacts with TEP1-RBD in vitro. Mutations in VR that disrupt base pairing near the VR central loop enhance binding to TEP1 in vitro, which suggests that this could be the case, and that these mutations might partially compensate for the absence of factors promoting the TEP1-VR interaction in vivo. Such missing factors could include MVP, VPARP and, in particular, the La RNA-binding protein, which binds VR stably apart from the vault particle and loosely purifies with vaults, suggesting that it may promote the VR-TEP1 interaction in vaults. Additionally, the full-length TEP1 contains a putative NTPase motif, which could potentially regulate the association of TEP1 with VR. Thus far, we have been unable to purify sufficient quantities of recombinant TEP1 containing both the p80 and putative NTPase regions to test this hypothesis, since TEP1 is particularly susceptible to degradation when expressed in insect cells. Finally, it is difficult to rule out misfolding of either RNA or the TEP1-RBD protein when conducting in vitro experiments using purified components, either of which could affect the specificity and stability of the RNA-protein interaction.
###end p 36
###begin p 37
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 441 449 441 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 784 792 784 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 88 93 <span type="species:ncbi:9606">human</span>
It was surprising that wild-type mouse VR did not readily interact with TEP1-RBD, since human VR1, mutant mVR, TR and a non-specific RNA did interact. Genetic evidence has demonstrated that TEP1 directs VR to the vault particle and influences its stability in vivo. Therefore, this study suggests that additional components are probably required for TEP1 to bind specifically to RNA. The complexity of reconstituting the TEP1-VR interaction in vitro may explain why non-specific binding of some RNAs to TEP1 is observed in the current study, and also why studies of p80-TR binding also reported non-specific binding of RNA (19). Overall, these results indicate that binding of RNA to TEP1 may be regulated by other cellular factors and suggest that the RNA-binding properties of TEP1 in vitro are probably similar to those seen with p80.
###end p 37
###begin p 38
###xml 475 480 <span type="species:ncbi:4932">yeast</span>
###xml 605 610 <span type="species:ncbi:4932">yeast</span>
This work was supported by grants from the G. Harold and Leila Y. Mathers Charitable Foundation (01124244 to L.H.R.), the National Science Foundation (MCB-0210690 to L.H.R.) and the NIH (AG16629-01 to L.H.). We thank the following members of the Harrington laboratory for their experimental contributions: Bryan Snow for construction of the 1-911 amino acid TEP1 baculovirus construct, Isabel Arruda for unpublished preliminary results in mapping the minimal TEP1-RBD in the yeast three-hybrid assay and Alexandra Reda for unpublished results that 1-223 nt mTR is sufficient to interact with mTep1 in the yeast three-hybrid assay. Funding to pay the Open Access publication charges for this article was provided by the G. Harold and Leila Y. Mathers Charitable Foundation.
###end p 38
###begin title 39
REFERENCES
###end title 39
###begin article-title 40
Isolation and characterization of a novel ribonucleoprotein particle: large structures contain a single species of small RNA
###end article-title 40
###begin article-title 41
Vaults. II. Ribonucleoprotein structures are highly conserved among higher and lower eukaryotes
###end article-title 41
###begin article-title 42
Structure of the vault, a ubiquitous cellular component
###end article-title 42
###begin article-title 43
Assembly of vault-like particles in insect cells expressing only the major vault protein
###end article-title 43
###begin article-title 44
Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex
###end article-title 44
###begin article-title 45
Characterization of the sea urchin major vault protein: a possible role for vault ribonucleoprotein particles in nucleocytoplasmic transport
###end article-title 45
###begin article-title 46
###xml 47 52 <span type="species:ncbi:9606">human</span>
The drug resistance-related protein LRP is the human major vault protein
###end article-title 46
###begin article-title 47
Vaults are up-regulated in multidrug-resistant cancer cell lines
###end article-title 47
###begin article-title 48
The major vault protein is a novel substrate for the tyrosine phosphatase SHP-2 and scaffold protein in epidermal growth factor signaling
###end article-title 48
###begin article-title 49
###xml 18 24 <span type="species:ncbi:10090">murine</span>
Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics
###end article-title 49
###begin article-title 50
###xml 39 42 <span type="species:ncbi:10116">rat</span>
###xml 47 55 <span type="species:ncbi:8400">bullfrog</span>
Vault ribonucleoprotein particles from rat and bullfrog contain a related small RNA that is transcribed by RNA polymerase III
###end article-title 50
###begin article-title 51
The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase
###end article-title 51
###begin article-title 52
Vaults and telomerase share a common subunit, TEP1
###end article-title 52
###begin article-title 53
RNA location and modeling of a WD40 repeat domain within the vault
###end article-title 53
###begin article-title 54
Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme
###end article-title 54
###begin article-title 55
A mammalian telomerase-associated protein
###end article-title 55
###begin article-title 56
TLP1: a gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
###end article-title 56
###begin article-title 57
The Tetrahymena p80/p95 complex is required for proper telomere length maintenance and micronuclear genome stability
###end article-title 57
###begin article-title 58
Tetrahymena proteins p80 and p95 are not core telomerase components
###end article-title 58
###begin article-title 59
Holoenzyme proteins required for the physiological assembly and activity of telomerase
###end article-title 59
###begin article-title 60
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo
###end article-title 60
###begin article-title 61
The Telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle
###end article-title 61
###begin article-title 62
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo
###end article-title 62
###begin article-title 63
The La RNA-binding protein interacts with the vault RNA and is a vault-associated protein
###end article-title 63
###begin article-title 64
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Identification of conserved vault RNA expression elements and a non-expressed mouse vault RNA gene
###end article-title 64
###begin article-title 65
###xml 9 14 <span type="species:ncbi:9606">human</span>
Multiple human vault RNAs. Expression and association with the vault complex
###end article-title 65
###begin article-title 66
Vaults. III. Vault ribonucleoprotein particles open into flower-like structures with octagonal symmetry
###end article-title 66
###begin article-title 67
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
A three-hybrid system to detect RNA-protein interactions in vivo
###end article-title 67
###begin article-title 68
Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP
###end article-title 68
###begin article-title 69
The TROVE module: a common element in Telomerase, Ro and Vault ribonucleoproteins
###end article-title 69
###begin article-title 70
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo selection of RNAs that localize in the nucleus
###end article-title 70
###begin article-title 71
###xml 0 24 0 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 0 24 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Saccharomyces cerevisiae telomerase is an Sm small nuclear ribonucleoprotein particle
###end article-title 71
###begin article-title 72
###xml 101 108 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo
###end article-title 72
###begin article-title 73
Mfold web server for nucleic acid folding and hybridization prediction
###end article-title 73
###begin article-title 74
###xml 74 79 <span type="species:ncbi:9606">human</span>
Structural analyses of the 7SK ribonucleoprotein (RNP), the most abundant human small RNP of unknown function
###end article-title 74
###begin article-title 75
Structural domains of vault proteins: a role for the coiled coil domain in vault assembly
###end article-title 75
###begin article-title 76
###xml 33 38 <span type="species:ncbi:9606">human</span>
Molecular analysis of the 60-kDa human Ro ribonucleoprotein
###end article-title 76
###begin article-title 77
RNA recognition by RNP proteins during RNA processing
###end article-title 77
###begin article-title 78
Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere
###end article-title 78
###begin article-title 79
Analysis of protein-RNA interactions within Ro ribonucleoprotein complexes
###end article-title 79
###begin title 80
Figures and Tables
###end title 80
###begin p 81
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 268 269 268 269 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
###xml 235 240 <span type="species:ncbi:4932">yeast</span>
###xml 271 276 <span type="species:ncbi:4932">Yeast</span>
###xml 359 365 <span type="species:ncbi:10090">murine</span>
###xml 442 447 <span type="species:ncbi:4932">Yeast</span>
Yeast three-hybrid analysis of TEP1 deletions and vault/telomerase RNAs. (A) TEP1 truncations were made using amino acids 1-871 as a starting point, since this region of human TEP1 interacts with human vault and telomerase RNAs in the yeast three-hybrid system (16). (B) Yeast strain L40i was transformed with plasmids expressing the above TEP1 deletions and murine vault or telomerase RNA in either sense (s) or antisense (as) orientations. Yeast were grown on synthetic drop-out plates lacking uracil, leucine and histidine, and containing 5 mM 3-aminotriazole (+3AT) or synthetic media lacking only uracil and leucine (-3AT). Growth on +3AT media indicates a TEP1-RNA interaction. No TEP1 deletions interacted with antisense RNA constructs (data not shown), but this is shown above only for those TEP1 deletions that interact with RNA in the sense orientation (constructs 1 and 2).
###end p 81
###begin p 82
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 92 93 92 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E.coli</italic>
###xml 356 357 356 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 423 425 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 697 700 697 700 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phe</sup>
###xml 988 989 988 989 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 19 25 <span type="species:ncbi:10090">murine</span>
###xml 118 124 <span type="species:ncbi:10090">murine</span>
###xml 148 154 <span type="species:ncbi:562">E.coli</span>
###xml 379 384 <span type="species:ncbi:10090">mouse</span>
Partially purified murine TEP1-RBD interacts with TR in vitro but has limited specificity. (A) Amino acids 201-871 of murine TEP1 were expressed in E.coli and partially purified using the hexahistidine tag derived from the pET28a vector. Shown are a Coomassie-stained gel (left panel) and western blot (right panel) using anti-TEP1 polyclonal antibodies. (B) EMSA of nt 1-223 of mouse TR incubated with TEP1-RBD. Five fmol 32P-labeled probe was incubated with 0, 5, 20 and 80 ng TEP1-RBD (lanes 1-4). Probe was competed off with 50x full-length TR (lane 5) and increasing amounts of mVR double point mutant (lanes 7 and 8), but not wild-type mVR (lane 6). The 250x unlabeled 5S Ribosomal RNA, tRNAphe or an artificial RNA (NL15) do not compete with the probe (lanes 7-9), but 50x excess of an artificial RNA derived from the pBluescript polylinker region does compete efficiently (lane 10). Labeled RNA is indicated with a black dot and shifted complexes are indicated with an asterisk. (C) Immunoprecipitation of TEP1-RBD from binding reactions using anti-T7 monoclonal antibody co-immunoprecipitates the TR transcript. Equivalent amounts of the bound (B) and unbound (U) fraction were analyzed by either western blot using anti-TEP1 polyclonal antibody (upper panel) or by fractionation on a 10% acrylamide/8 M urea gel (lower panel). The latter gel was dried and radioactive bands visualized by phosphorimager analysis. Antibodies to the T7 epitope (lanes 1 and 2), but not antibodies to the FLAG (lanes 3 and 4) and VSVG (lanes 5 and 6) epitopes, immunoprecipitated both TEP1-RBD and TR.
###end p 82
###begin p 83
###xml 60 61 60 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 132 134 132 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 287 288 287 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 861 862 861 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 15 21 <span type="species:ncbi:10090">murine</span>
###xml 144 150 <span type="species:ncbi:10090">murine</span>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
###xml 499 504 <span type="species:ncbi:10090">mouse</span>
###xml 707 712 <span type="species:ncbi:10090">mouse</span>
###xml 733 738 <span type="species:ncbi:9606">human</span>
###xml 993 998 <span type="species:ncbi:10090">mouse</span>
###xml 1093 1098 <span type="species:ncbi:10090">mouse</span>
Mutagenesis of murine VR enhances its binding to TEP1-RBD. (A) EMSA of VR-TEP1-RBD complexes. Binding reactions contained 5 fmol of 32P-labeled murine VR (left panel) or human VR1 (right panel) incubated with 0 (lanes 1 and 4), 20 (lanes 2 and 5) and 80 (lanes 3 and 6) ng of TEP1-RBD. (B) EMSA of VR probes (5 fmol) without (-) or with (+) 80 ng TEP1-RBD in the binding reaction. Wild-type mouse VR interacts poorly or not at all with TEP1-RBD (lanes 1 and 2), but a highly related sequence in the mouse genome that is not expressed binds more strongly (lanes 3 and 4). A VR double point mutant G70A, C73U (lanes 5 and 6) binds more strongly to TEP1-RBD. Also shown are the corresponding single mutants in mouse VR (lanes 7-10) and human VR1 (lanes 11 and 12). Labeled RNAs are indicated with a black dot and shifted complexes are indicated with an asterisk. (C) The thermodynamically predicted secondary structure of the wild-type (left structure) and double point mutant (center structure) mouse VR, focusing on the regions of interest only. Also shown is the entire predicted structure of mouse VR, along with the position of the double point mutant and the C78 to A mutation, which has enhanced binding.
###end p 83
###begin p 84
###xml 396 404 396 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2</xref>
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
The mVR point mutant competes with TR for binding to TEP1-RBD. EMSA of mVR double point mutant incubated with 0, 5, 20 and 80 ng of TEP1-RBD (lanes 1-4). Unlabeled mVR mutant or mouse TR (50x) competes with the labeled probe (lanes 5 and 6). Three irrelevant RNAs do not compete with TR for binding to TEP1-RBD (lanes 7-9), but the pBluescript transcript does compete efficiently (lane 10) as in Figure 2. Labeled RNA is indicated with a black dot and shifted complexes are indicated with an asterisk.
###end p 84
###begin p 85
###xml 54 55 54 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 556 557 556 557 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 176 179 <span type="species:ncbi:10116">rat</span>
###xml 587 590 <span type="species:ncbi:10116">rat</span>
###xml 598 603 <span type="species:ncbi:9606">human</span>
RNase H digests of vault-bound and deproteinated VR. (A) Oligodeoxynucleotide-directed RNase H cleavage of the VR. P100 extract (RNP) or deproteinized P100 (RNA) purified from rat fibroblasts (left panel) or HeLa cells (right panel) was incubated with the indicated antisense ODN and RNase H. RNA was extracted from each sample and fractionated on a 10% denaturing polyacrylamide gel. The gel was electroblotted to a Zeta GT+ membrane and probed with the randomly primed VR gene. Intact VR is indicated by the arrow, and lower bands represent cleaved VR. (B) Thermodynamic prediction of rat VR and human VR1 secondary structures. The lines indicate regions of single-stranded RNA based upon RNase H digests of vault-associated VR.
###end p 85
###begin p 86
###xml 72 73 72 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 183 184 183 184 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
The p80 homology region of TEP1 contains the vault interaction domain. (A) TEP1 truncations were co-expressed with the MVP in Sf9 insect cells using a baculovirus expression vector. (B) MVP forms vaults when expressed in insect cells, which are found entirely in the high-speed pellet (P100) of cell lysates and can be purified to near-homogeneity. Vault-interacting proteins will co-purify with vaults. Vaults were further enriched, and as a final step, samples were loaded onto a 20-60% sucrose gradient and centrifuged for 16 h. Sucrose fractions were pelleted, resuspended in 20 mM MES buffer, pH 6.5 and analyzed by western blot. Vaults fractionate largely in the 45% sucrose layer (upper panel). In the absence (-) of MVP-baculovirus co-infection, TEP1 truncations fractionate in either the high-speed supernatant (S100), P100, or both, and are lost in the purification scheme before the sucrose gradient step (1, 2, and 3, upper panels). When MVP is present (+), TEP1 truncations able to interact with vaults are found largely in the 45% sucrose layer (column 1, 2, and 3, lower panels).
###end p 86
###begin p 87
Stepwise reversion of PsimVR to mVR sequence
###end p 87
###begin p 88
The position of the 8 nt differences between the two RNAs are shown in the leftmost column, and the base found in PsimVR and mVR at each is indicated. Columns 1-6 are variant VRs tested for binding to TEP1-RBD, with the result shown in the bottom row.
###end p 88

